Abstract

Hepatitis C virus (HCV) cause both chronic and acute hepatitis, depends on the severity from mild to serious illness, leads a lifelong illness, such as liver cancer and liver cirrhosis. Chronic HCV is generally a silent infection for several years, until it damages the liver. Diagnosing HCV infection in a regular basis is mandatory and this research focused to quantify hepatitis C-core antigen (HCVcoreAg) on aptamer-gold modified dielectrode silica surface. Aptamer-biotin was immobilized on the electrode by using streptavidin-gold nanoparticle interaction, which enhance the number of aptamer attachment on interdigitated dielectrode (IDE). Further, aptamer-antibody sandwich assay was carried out to increase the analytical performance for HCVcoreAg detection and reached a limit of detection to 0.5 pg/mL on a linear increment range from 0.5 to 16 pg/mL with an acceptable regression coefficient [y = 1.0116×−1.372; R2 = 0.963]. In addition, blocking agent PEG-b-PAAc reduced the biofouling on IDE and control the increment of current responses in non-specific experiments, which helps to detect the HCVcoreAg in mixed biological samples without interferences. This sandwich assay detects the lower level of HCVcoreAg and diagnose HCV infection.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call